Ophthalmic manifestations of multiple myeloma

West African Journal of Medicine

Volumn 26, Issue 4, 2007, Pages 265-268

  Omoti, Afe E ^a   Omoti, C E ^a  

^a UNIVERSITY OF BENIN   (Nigeria)

Author keywords

Hyperviscosity syndrome; Multiple myeloma; Ophthalmic manifestations

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN LIGHT CHAIN;

CELL PROLIFERATION; CLINICAL FEATURE; CONFUSION; CONJUNCTIVA DISEASE; CONSCIOUSNESS DISORDER; CORNEA DISEASE; CRANIAL NERVE PARALYSIS; CYST; DIPLOPIA; DISEASE ACTIVITY; EARLY DIAGNOSIS; EARLY INTERVENTION; ECCHYMOSIS; EFFUSION; EPISCLERITIS; EXOPHTHALMOS; EYE DISEASE; EYE EXAMINATION; EYELID DISEASE; GAIT DISORDER; HUMAN; IRIS DISEASE; LOW DRUG DOSE; MEDICAL RECORD REVIEW; MORBIDITY; MULTIPLE MYELOMA; NEUROLOGIC DISEASE; NEUROOPHTHALMOLOGY; NONHUMAN; PLASMACYTOMA; RELAPSE; RETINA DETACHMENT; RETINA VASCULITIS; RETINOPATHY; REVIEW; SCLERITIS; SECONDARY GLAUCOMA; VISUAL IMPAIRMENT; XANTHOMATOSIS;

EYE DISEASES; HUMANS; MULTIPLE MYELOMA;

EID: 44949129295     PISSN: 0189160X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Sirohi B, Powles R. Multiple myeloma. Lancet 2004; 363: 875-87.
2. Riedel DA, Pottern LM. The epidemiology of multiple myeloma. Hematol Oncol Clin North Am 1992; 6: 225-47.
3. Barlogie B, Shaughnessy J, Munshi N, Epstein J. Plasma cell myeloma. In: Beutler E, Lichtman MA, Coller BS, Kipps TI (eds). Williams Haematology 6th ed. New York. McGraw-Hills; 1996: 1279-1301.
4. Greenlee RT, Murray T, Bolden S, Wingo A. Cancer Statistics 2000; 50: 7.
5. Tariman JD. Understanding novel therapeutic agents for multiple myeloma. Clin J Oncol Nurs 2003; 7: 521-8.
6. Bataille R, Harousseau JL. Multiple myeloma. N Engl J Med 1997; 336: 1657-1664.
7. Dimopoulos MA, Moulopoulos LA, Mannitis A, Alexanian R. Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Blood 2000; 96: 2037-2044.
8. Kyle RA, Therneau TM, Rajkumar SV et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Eng l J Med 2002; 346: 564-569.
9. Goldstein DA, Schteingart MT, Bimbaum AD, Tessler HH. Bilateral eyelid ecchymoses and cornea crystals: an unusual presentation of multiple myeloma. Cornea 2005; 24: 757-8.
10. Benjamin I, Taylor H, Spindler J. Orbital and conjuctival involvement in multiple myeloma. Report of a case. Am J Clin Pathol 1975; 63: 811-7.
11. Fung S, Selva D, Leibovitch I, Hsuan J, Crompton J. Ophthalmic manifestations of multiple myeloma. Ophthalmologica 2005; 219: 43-8.
12. Boyadjis TA, D'Altorio RA. Orbital involvement by multiple myeloma: case report. J Comput Tomogr 1986; 10: 145-6.
13. Knapp AJ, Gartner S, Henkind P. Multiple myeloma and its manifestations. Surv Ophthalmol 1987; 31: 343-51.
14. Kottler UB, Cursiefen C, Holbach LM. Orbital involvement in multiple myeloma: first sign of insufficient chemotherapy. Ophthalmologica 2003; 217: 76-8.
15. Khouri GG, Murphy RP, Kuhajda FP, Green WR. Clinicopathologic features in two cases of multiple myeloma. Retina 1986; 6: 169-75.
16. Orellana J, Friedman AH. Ocular manifestations of multiple myeloma, Waldenstrom's macroglobulinaemia and benign monoclonal gammopathy. Surv Ophthalmol 1981; 26: 157-69.
17. Fay AM, Leib ML, Fountain KS. Multiple myeloma involving the orbit. Ophthal Plast Reconstr Surg 1998; 14: 67-71.
18. Brian GM, Giles D, Giles F. Myelomatosis (multiple myeloma). In: Hoffbrand AV, Lewis SM, Tuddenham EGD (eds). Postgraduate Haematology. Butterworths-Heinemann. Oxford. 1999: 462-478.
19. Levin SR, Spaulding AG, Wirman JA. Multiple myeloma. Orbital involvement in a youth. Arch Ophthalmol 1977; 95: 642-4.
20. De Potter P, Disneur D, Levecq L, Snyers B. Ocular manifestations of cancer, J Fr Ophtalmol 2002; 25: 194-202.
21. Adkins JW, Shields JA, Shields CL, Eagle RC Jr, Flanagan JC, Campanella PC. Plasmacytoma of the eye and orbit, Int-Ophthalmol 1996; 20: 339-43.
22. Balavre S, Gicquel JJ, Mercie M, Dighiero P. Orbital extension of sinus plasmacytoma secondarily transforming into multiple myeloma: a case study. J Fr Ophtalmol 2004; 27: 67-71.
23. Tuncbilek N, Karakas HM, Okten OO, Vural O. MRI in multiple myeloma with orbital and dural invasion. Tumori 2005; 91: 270-2.
24. Mehta J, Singhal S. Hyperviscosity syndrome in plasma cell dyscrasias. Semin Thromb Hemost 2003; 29: 467-71.
25. Kes P, Pecanic Z, Getaldic B, Ratkovic-Gusic I. Treatment of hyperviscosity syndrome in the patients with plasma cell dyscrasias. Acta Med Croatia 1996; 50: 173-7.
26. Beebe WE, Webster RG Jr, Spencer WB. A typical corneal manifestations of multiple myeloma. A clinical, histopathologic, and immunohistochemical report. Cornea 1989; 8: 274-80.
27. Chong EM, Campbell RJ, Bourne WM. Vortex keratopathy in a patient with multiple myeloma. Cornea 1997; 16: 592-4.
28. Daicker BC, Mihatsch MJ, Strom EH, Fogazzi GB. Ocular pathology in light chain deposition disease. Eur J Ophthalmol 1995; 5: 75-81.
29. Ajithkumar TV, Sivasankar C, Ramachandran K. Orbital multiple myeloma: case report and review of computed tomography features. Australas Radiol 2002; 46: 119-20.
30. Willinsky RA, Cooper PW, Kassel EE. CT of myeloma involving the skull base. J Can Assoc Radiol 1985; 36: 328-31.
31. Keung YK, Yung C, Wong JW, Shah F, Cobos E. Association of temporal arteritis, retinal vasculitis, and xanthomatosis with multiple myeloma: case report and literature review. Mayo Clin Proc 1998; 73: 657-60.
32. Codere F, Lee RD, Anderson RL. Necrobiotic xanthogranuloma of the eyelid. Arch Ophthalmol 1983; 101: 60-3.
33. Robertson DM, Winkelmann RK. Ophthalmic features of necrobiotic xanthogranuloma with paraproteinaemia. Am J Ophthalmol 1984; 97: 173-83.
34. Kleta R, Blair SC, Bemardini I, Kaiser-Kupfer MI, Gahl WA. Keratopathy of multiple myeloma masquerading as corneal crystals of ocular cystinosis. Case report. Mayo Clin Proc 2004; 79: 410-412.
35. Hutchinson K, Dal Pra M, Apel A. Immunoglobulin G crystalline keratopathy associated with monoclonal gammopathy. Aust N Z J Ophthalmol 1998; 105: 99-103.
36. Miller KH, Green WR, Stark WJ, Wells HA, Mendelsohn G, Kanhofer H. Immunoprotein deposition in the cornea. Opthalmology 1980; 87: 944-950.
37. Klintworth GK, Bredehoeft SJ, Reed JW. Analysis of corneal crystalline deposits in multiple myeloma. Am J Ophthalmol 1978; 86: 303-313.
38. Michau TM, Proulx DR, Rushton SD, Olivry T, Dunston SM, Gilger BC et al. Intraocular extramedullary plasmacytoma in a cat. Vet Ophthalmol 2003; 6: 177-81.
39. Pizzuti P, Pertuiset E, Chaumonnot F, Chesneau A, Mikol J, Leblond-Missenard V et al. Neuromeningeal sites of multiple myeloma: 3 cases and review of the literature. Rev Med Interne 1997; 18: 646-51.